Business · Companies · 1 hr ago
OmniActive explores $200-300 million IPO at nearly $1 billion valuation
OmniActive Health Technologies is exploring an IPO that could raise $200-300 million and value the company at nearly $1 billion.
The company, led by Sanjay Mariwala, makes ingredients for health supplements, fortified foods and drinks, and serves customers around the world.
The IPO discussions are still at an early stage, and any offering could combine new shares with existing investors selling some of their holdings.
US private equity firm TA Associates held about 56% of OmniActive as of September 2025, while the Mariwala family owned 40%.
An IPO would make it the first listed pure-play nutraceutical company, if the plan goes ahead.
OmniActive said it is financially strong and is not pursuing a private capital raise, while adding that it regularly reviews strategic opportunities.
There is no definitive transaction under consideration, so the company has not set out a confirmed IPO timetable.
OmniActive Health Technologies is exploring an initial public offering that could raise $200 million to $300 million and value the company at nearly $1 billion.
The discussions with bankers are at an exploratory stage, according to people familiar with the matter.
The company said it is not pursuing a private capital raise and that no definitive transaction is under consideration.
The proposed IPO follows several unsuccessful attempts to raise private capital, amid economic headwinds and geopolitical conflicts.
If completed, the listing would make OmniActive the first pure-play nutraceutical company to list on the exchanges.
- Who
- OmniActive Health Technologies, led by Sanjay Mariwala. TA Associates and the promoter group could sell shares.
- What
- The company is exploring an IPO that could raise $200 million to $300 million and value it at nearly $1 billion.
- When
- Discussions with bankers had begun by 23 October 2026.
- Where
- The company serves global customers and has offices in India, New Jersey in the US, and the Netherlands.
- Why
- The plan follows unsuccessful attempts to raise private capital. The sources say economic headwinds and geopolitical conflicts weighed on investor sentiment.
People familiar with OmniActive's plans
OmniActive
IPO discussions
People familiar with OmniActive's plans
The company has begun discussions with bankers to explore an IPO that could raise $200 million to $300 million.
OmniActive
The company said it is not pursuing a private capital raise and that no definitive transaction is under consideration.
Transaction status
People familiar with OmniActive's plans
The talks are at an exploratory stage and could include new shares and an offer for sale.
OmniActive
The company said there was no material development or definitive transaction requiring disclosure.
Sanjay Mariwala partnered with Hiren Doshi to set up OmniActive.
TA Associates acquired a majority stake in OmniActive while facilitating Everstone Capital's exit.
IIFL Asset Management acquired a minority stake in the company.
TA Associates held about 56% of OmniActive, while the Mariwala family owned 40%.
OmniActive's discussions with bankers to explore an IPO were reported as being at an exploratory stage.
- Potential IPO size
- $200 million to $300 million
- Potential valuation
- Nearly $1 billion
- TA Associates' stake
- About 56% as of September 2025
- Mariwala family's stake
- 40% as of September 2025
- FY25 operating income
- About ₹886 crore
- Company offices
- India, New Jersey in the US, and the Netherlands
What people are saying
OmniActive Health Technologies remains financially strong, with a robust balance sheet, healthy cash reserves, and a debt-free capital structure.
Given this strong financial foundation, we are focused on executing our growth strategy and creating enduring value for stakeholders.
As part of prudent business planning, we periodically assess a range of strategic opportunities; however, there is no material development or definitive transaction under consideration that requires disclosure at this time,